| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -16,673 | -12,250 |
| Depreciation and amortization | 300 | 223 |
| Stock-based compensation expense | 827 | 300 |
| Noncash financing expenses | 3,061 | 3,061 |
| Grant receivable | - | 450 |
| Change in fair value of derivative instruments | 2,631 | 2,631 |
| Accretion of discount on short-term investments | 19 | 22 |
| Reduction in the carrying amount of operating lease right-of-use assets | 53 | 44 |
| Gain on sale of assets | 16 | 16 |
| Other assets | -635 | - |
| Other current assets | - | 265 |
| Accounts payable and accrued expenses | -6,308 | -5,181 |
| Change in operating lease liabilities | -54 | -45 |
| Deferred grant liability | 1,045 | - |
| Net cash used in operating activities | -14,518 | -11,970 |
| Purchases of property and equipment | 37 | 10 |
| Proceeds from sale of property and equipment | 30 | 30 |
| Purchase of short-term investments | 11,068 | 7,756 |
| Redemption of short-term investments | 11,305 | 6,662 |
| Purchase of intangible assets | 7 | - |
| Net cash provided by (used in) investing activities | 223 | -1,074 |
| Repayment of credit facility | 3,292 | 3,292 |
| Payment of financing costs | 2,250 | - |
| Proceeds from issuance of notes payable and warrants | 3,738 | 3,738 |
| Repayment of notes payable | 3,703 | 3,703 |
| Proceeds from exercise of series b warrants from may 2024 pipe | - | 882 |
| Proceeds from sale of common stock, pre-funded warrants and warrants | 15,927 | 15,001 |
| Proceeds from sale of common stock under lincoln park purchase agreement | 19,612 | 2,795 |
| Payment to investors pursuant to letter agreement (note 13) | 2,293 | - |
| Offering costs for sale of common stock | 231 | 220 |
| Net cash provided by financing activities | 27,508 | 15,201 |
| Net increase (decrease) in cash and cash equivalents | 13,213 | 2,157 |
| Cash and cash equivalents at beginning of period | 76 | - |
| Cash and cash equivalents at end of period | 13,289 | - |
PLUS THERAPEUTICS, INC. (PSTV)
PLUS THERAPEUTICS, INC. (PSTV)